Investing In Bionano Genomics Inc (NASDAQ: BNGO): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

The company is listed on the NASDAQ and operates within the Medical Instruments & Supplies industry segment. The current market capitalization of Bionano Genomics Inc is $60.71M. A total of 1.71 million shares were traded on the day, compared to an average of 1.69M shares.

In the most recent transaction, Mamuszka Hannah bought 65,789 shares of BNGO for 0.76 per share on Jun 13 ’23. After the transaction, the Director now owns 65,789 company shares. In a previous transaction on May 16 ’23, Holmlin R. Erik bought 15,000 shares at 0.64 per share. BNGO shares that President and CEO owns now total 806,474.

Among the insiders who bought shares, Stewart Christopher P. acquired of 50,000 shares on May 12 ’23 at a per-share price of $0.67. This resulted in the Chief Financial Officer holding 281,373 shares of BNGO after the transaction.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, BNGO has a high of $11.80 and a low of $1.00.

As of this writing, BNGO has an earnings estimate of -$0.87 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.75 per share and a lower estimate of -$1.01. The company reported an EPS of -$1.24 in the last quarter, which was -20.40% lower than expectations of -$1.03.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BNGO’s latest balance sheet shows that the firm has $250.61M in Cash & Short Term Investments as of fiscal 2021. There were $10.70M in debt and $21.84M in liabilities at the time. Its Book Value Per Share was $2.10, while its Total Shareholder’s Equity was $337.12M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BNGO is Buy with a score of 4.50.

Most Popular

Related Posts